Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Source: Fool - Investing News
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.